
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PFE | NYSE | USD | Real-time | |
PFE | Mexico | MXN | Delayed | |
PFE | Stockholm | SEK | Real-time | |
PFE | Frankfurt | EUR | Delayed | |
PFE | TradeGate | EUR | Delayed | |
PFE | Hamburg | EUR | Delayed | |
PFE | Xetra | EUR | Delayed | |
PFE | Santiago | USD | Delayed | |
PFE | Buenos Aires | ARS | Delayed | |
PFIZ34 | BM&FBovespa | BRL | Delayed | |
PFE | Vienna | EUR | Delayed | |
PFE_KZ | KASE | USD | Delayed | |
PFE | Colombia | COP | Delayed | |
PFE | Lima | USD | Delayed |
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The Company's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.
Name | Age | Since | Title |
---|---|---|---|
Susan J. Hockfield | 70 | 2020 | Independent Director |
Daniel R. Littman | 69 | 2018 | Independent Director |
Albert Bourla | 60 | 2016 | Chairman of the Board & CEO |
Suzanne M. Nora Johnson | 65 | 2007 | Independent Director |
Ronald E. Blaylock | 62 | 2017 | Independent Director |
James C. Smith | 62 | 2014 | Independent Director |
Shantanu Narayen | 58 | 2013 | Lead Independent Director |
Helen H. Hobbs | 70 | 2011 | Independent Director |
Joseph J. Echevarria | 65 | 2015 | Independent Director |
James Robert B. Quincey | 57 | 2020 | Independent Director |
Scott Gottlieb | 49 | 2019 | Independent Director |
Charles T. Hagel | 76 | - | Member of Emerging Markets Advisory Board |
Susan Desmond-Hellmann | 65 | 2020 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review